Skip to main content

Table 2 Patient characteristics during ICU stay

From: Factors predicting prolonged empirical antifungal treatment in critically ill patients

Patient characteristics

Prolonged empirical antifungal treatment

p value

 

Yes n = 77

No n = 76

 

Multifocal fungal colonization

24 (31)

35 (46)

0.076

Antimicrobial treatment

73 (94)

70 (93)

0.744

Mechanical ventilation

59 (76)

67 (88)

0.059

Duration of mechanical ventilation, d

12.5 (4, 25)

20 (0, 36)

0.007

Central venous catheter

69 (89)

71 (93)

0.396

Duration of central venous catheter use, d

13 (4, 20)

18 (10, 25)

0.015

Arterial catheter

62 (81)

71 (93)

0.025*

Duration of arterial catheter use, d

8 (3, 15)

13 (10, 20)

0.002

Dialysis

30 (39)

28 (37)

0.97

Parenteral nutrition

26 (33)

29 (38)

0.571

Duration of antifungal treatment, d

9 (4, 19)

6 (2, 11)

0.003

Percentage of days in the ICU with antifungals

80 (65, 100)

25 (13, 35)

<0.001

Length of ICU stay, d

14 (5, 27)

22 (14, 39)

0.001

ICU mortality

36 (46)

39 (52)

0.518

  1. *OR (95% CI) 0.3 (0.1-0.9).
  2. Data are n (%), or median (25th, 75th IQR).
  3. ICU, intensive care unit.